Drugs / Levora
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01236768 Comparator | Oct 2010 → Jun 2011 | — | Agile Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levora | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01236768 ↗ |
| Route | Oral | “oral contraceptive containing 150mcg of LNG and 30mcg of EE” NCT01236768 ↗ |